Quiet and Overbought
Markets are quiet, calm and overbought. Productivity lags, again. Credit growth hits a record. What will Draghi buy? Goldman investigated for Bank Secrecy Act. Valeant looks sick. Samsung has the next cool phone.
Financial Review by Sinclair Noe for 06-07-2016
DOW + 17 = 17,938
SPX + 2 = 2112
NAS – 6 = 4961
10 Y – .01 = 1.71%
OIL + .74 = 50.43
GOLD – 1.50 = 1244.20
Fed chief Janet Yellen on Monday called last week’s U.S. jobs numbers disappointing and opted not to repeat her message that U.S. interest rates could rise again in the coming months. That was balanced, however, by her cautioning against attaching too much significance to the payrolls data in isolation and as she pointed to other more upbeat signals for the economy and indicated rate hikes this year would still be appropriate. On Friday, when the jobs report came in at a very weak 38,000 jobs added, the markets were down slightly. Clearly the news from the jobs report had the effect of taking a June rate hike off the table. In the past, the markets would have rallied on that kind of news, but it made for terrible optics, and so we had to wait for Fed chair Yellen to not say anything. And besides, the markets had already priced in no rate hike in June. So, what’s going on here?
The S&P 500 has gone 42 trading days without a decline of 1% or more. That’s the longest stretch without a big drop since a 66-day period that ended in July 2014, according to FactSet. The U.S. stock market hasn’t dropped by 1% or more since April 7. During one particularly scary stretch in mid-February, the S&P 500 suffered three plunges of 1% or more on separate occasions in just five days. This slow steady advance leaves the market in extremely overbought territory.
Economic data remains weak; we just wrapped up another horrible earnings season; valuations remain expensive; we are moving into a seasonally weak time period; the yield curve is flattening; volume is weak. Meanwhile, the bullish case for this market is tenuous at best. It might be bullish…, if the Fed keeps rates unchanged; if the economy bounces back in the second half (we’ve already given up on a second quarter bounce); if earnings improve (which is plausible given how low the bar is now set); if oil trades higher (even though higher oil prices will surely lead to higher supplies); if the dollar doesn’t firm up again; if there is no Brexit; and if the markets continue to ignore the data.
You get the idea. Still, it is possible to take out the old highs on the S&P, even without a bullish case. If that happens I would still be left wondering what is pushing the bullish case, other than a herd mentality that is not sustainable. Today, stocks moved to an 11 month high and then faltered on weak volume.
Productivity remains a key weakness of the economy and is especially evident during the low output of the first quarter. American workers were less productive again in the first quarter. The Labor Department productivity declined at an annual rate of 0.6 percent in the first quarter after a 1.7 percent drop in the fourth quarter. The government first estimated that productivity fell at a 1 percent rate. Not only did hours exceed output, compensation rose at the same time, up 3.9 percent to lift unit labor costs by 4.5 percent, even faster than the 4.1 percent gain first reported. Though there seems to still be a belief that wage growth remains sluggish, in reality, wages have finally begun to move higher in earnest. The anecdotal and survey evidence has been pointing to rising wages for a while, but the data were slow to fall into line. Now they have.
CoreLogic’s Home Price Index (HPI) shows that home prices in the USA are up 6.2 % year-over-year (reported up 1.8 % month-over-month). Last month’s 6.7 % year-over-year gain was revised downward to 5.5 %. CoreLogic HPI is used in the Federal Reserve’s Flow of Funds to calculate the values of residential real estate.
Consumer credit growth cooled off a bit in April from a torrid pace in March, according to the latest government estimates. Credit growth rose $13.4 billion in April, or at a seasonally adjusted annual rate of 4.5%, the Federal Reserve said Tuesday. Economists had expected a gain of $18 billion in April consumer credit. This is down from a revised $28.4 billion, or 9.6% pace in March. That was the largest dollar gain in consumer credit on record. The Fed said credit-card debt rose at a 2.1% rate in April, down from 13.3% in the prior month, which was the largest gain February 2001. Non-revolving debt, mainly car and student loans, which has powered credit growth in recent years, expanded at a 5.4% rate in April, below the 8.2% gain in March. As a result of the gain in April, total outstanding consumer credit reached an all-time peak of $3.6 trillion.
Even before Mario Draghi starts his corporate-bond buying program tomorrow, he’s pushed down borrowing costs in Europe toward unprecedented levels, with the average yield on euro investment-grade company notes tumbling to 1%. On Tuesday, a series of government bond yields tumbled to multi-month and all-time lows. The ECB in March announced it would expand its asset-purchasing program to include corporate bonds in an effort to directly lower borrowing costs for businesses and to help lift persistently low inflation. One concern is that corporate buybacks might have some unintended consequences, such as stock buybacks and widening spreads between bonds that are eligible for ECB’s purchases and those that aren’t.
Second-round bids for Yahoo’s internet business were due yesterday. Verizon Communications reportedly planned to submit a bid worth about $3 billion for Yahoo’s internet business, according to the Wall Street Journal. The telecom giant reportedly isn’t interested in other Yahoo assets such as patents and real estate. The private-equity firm TPG and a team led by Quicken Loans founder Dan Gilbert are said to be among the other interested parties. Yahoo is projected to hold at least one more cycle of bidding, and the offers could change by the final round.
U.S. investigators are trying to determine whether Goldman Sachs violated the Bank Secrecy Act when it didn’t sound an alarm over a suspicious transaction involving Malaysia’s state fund 1MDB. After raising $3 billion via a bond issue for the troubled fund, Goldman sent the proceeds to a Swiss bank account controlled by 1MDB, with half of the money disappearing offshore within days and some reappearing in the prime minister’s bank account.
Royal Dutch Shell will exit oil and gas operations in up to 10 countries in a drive to cut costs as it weathers weak oil prices and has to pay down debt following its $54 billion acquisition of BG Group. The company is active in more than 70 countries and said it would like to focus on 13 important nations where it is making good returns, including Brazil, Australia and the United States. The move, which includes the sale of 10 percent of its oil and gas production assets, will make Shell a smaller company that offers investors access to a more gas-heavy portfolio than some of its rivals.
Shares of Biogen dropped this morning after an experimental drug for multiple sclerosis failed in a mid-stage trial. The drug missed both the main and secondary goals for treating the disorder. Biogen makes most of its money from drugs treating MS and has been seeking new treatments to accelerate growth.
Valeant Pharmaceuticals announced a loss of $1.08 a share, which was adjusted to a gain of $1.27 when factoring out one-time adjustments. Valeant cut its 2016 earnings and sales forecasts, marking a major reset point as the once high-flying company tries to get back on its feet. First-quarter earnings — the last set of full results under former Chief Executive Officer Michael Pearson — gave investors the first detailed picture of the drugmaker’s struggles to sell its products during the recent months of chaos. Two of Valeant’s key categories, dermatology and prescription ophthalmology, slumped by 43 percent and 30 percent, respectively. In dermatology in particular, the company has faced pushback from health insurers and pharmacy benefit managers after increasing its prices.
A U.S. District Judge has found a pattern of misconduct by Merck including lying under oath and other unethical practices, freeing Gilead Sciences from paying damages for infringing on Merck’s patents with its hepatitis C treatments – Sovaldi and Harvoni. The ruling comes after a federal jury on March 24 ordered Gilead to pay $200 million in damages, based on findings that Merck’s patents were valid.
Samsung is considering introducing two new smartphone models that will feature bendable screens. One model is said to fold in half like a cosmetic compact, while the other has a 5-inch display that “unfurls” into a tablet-sized 8-inch panel. The devices using organic light-emitting diodes could be unveiled as soon as early 2017.
Leading European countries have decided not to extend the license for glyphosate, a herbicide used in Monsanto’s top selling weedkiller. The EU is worried about growing public concerns it could cause cancer.
Daimler is laying off more than 1,200 workers at three plants in the U.S. and one in Mexico, the second such cut this year in response to falling demand for commercial trucks. Last month, Daimler projected a 15% decline in North America sales of medium and heavy-duty trucks, warning that a slump in the market would significantly lower its earnings before interest and tax in 2016.
Ralph Lauren announced a restructuring plan. The company also plans to cut 8% of its workforce in the current fiscal year. As of April, it employed about 26,000 people around the world, 11,000 of whom are part-time workers. The planned job cuts will be in addition to the 5% workforce reduction that the company already implemented in its last fiscal year. The company plans to close about 50 stores. The company currently has 493 stores, including 216 in the U.S.